Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

JB-9315: a new H2 antagonist with both antisecretory and cytoprotective properties

Feb. 16, 1998

Plant extract DA-9601 protects against NSAID-induced gastric damage

Feb. 12, 1998

New agents for IBS from Nippon Shinyaku

Feb. 11, 1998

Maxamine/Infergen combination to be tested in clinic

Feb. 9, 1998

EMEA decision on Zacutex MAA deferred

Feb. 9, 1998

Schering-Plough discloses HCV NS3 protease inhibitors

Feb. 9, 1998

K+ channel blockers patented by HMR for ulcers, arrhythmias

Feb. 9, 1998

Pharmacia & Upjohn and Chiron establish HCV collaboration

Feb. 4, 1998

Prokinetic motilin agonists in development at Ohmeda

Jan. 30, 1998

Meiji Seika describes 5-HT3 partial agonists for GI disorders

Jan. 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...